Glans metastatic extra-nodal natural killer/T-cell lymphoma, nasal-type with HDAC inhibitor as maintenance therapy: a rare case report with literature review

被引:5
作者
Fu, Chunxi [1 ]
Yang, Chunli [1 ]
Li, Qiaoer [1 ]
Wang, Ling [2 ]
Zou, Liqun [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Oncol, 37 Guo Xue Xiang, Chengdu 610041, Peoples R China
[2] Sichuan Univ, Dept Dermatol, West China Hosp, Chengdu, Peoples R China
关键词
Extra-nodal natural killer/T-cell lymphoma (ENKTL); glans; histone deacetylase inhibitors (HDAC inhibitors); gene sequencing; case report; PHASE-II; CHEMOTHERAPY; SMILE;
D O I
10.21037/apm-19-430b
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Extra-nodal natural killer/T-cell lymphoma (ENKTL) is an aggressive lymphoid malignancy and advanced ENKTL is characterized by a dismal survival outcome. Distant metastasis is frequently common in advanced ENKTLs, while the glans is rarely involved. Here we report a 67-year-old Chinese male with glans metastasis ENKTL, nasal type secondary from the nasal cavity, treated with modified SMILE regimen plus glans radiotherapy and achieved a complete remission (CR). Since the poor prognosis of metastatic ENKTL and unfitness for hematological stem cell transplant (HSCT) we administered histone deacetylase MAC) inhibitor Chidamide as maintenance therapy, which was resulted in a progression-free survival (ITS) of 12 months. To investigate the gene alternations, the whole exon sequencing and the 446-gene panel sequencing were performed and we found the BCOR, KRAS, CDKN1B, XPO1, DOT1L, genes mutations. Best to our knowledge, this is a glans metastasis ENKTL with the longest PFS and die most successful treatment.
引用
收藏
页码:3602 / 3608
页数:7
相关论文
共 15 条
[1]   Increased incidence of penile cancer and high-grade penile intraepithelial neoplasia in Denmark 1978-2008: a nationwide population-based study [J].
Baldur-Felskov, Birgitte ;
Hannibal, Charlotte Gerd ;
Munk, Christian ;
Kjaer, Susanne K. .
CANCER CAUSES & CONTROL, 2012, 23 (02) :273-280
[2]   Incidence trends in primary malignant penile cancer [J].
Barnholtz-Sloan, Jill S. ;
Maldonado, John L. ;
Pow-Sang, Julio ;
Guiliano, Anna R. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2007, 25 (05) :361-367
[3]   Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type [J].
Dobashi, Akito ;
Tsuyama, Naoko ;
Asaka, Reimi ;
Togashi, Yuki ;
Ueda, Kyoko ;
Sakata, Seiji ;
Baba, Satoko ;
Sakamoto, Kana ;
Hatake, Kiyohiko ;
Takeuchi, Kengo .
GENES CHROMOSOMES & CANCER, 2016, 55 (05) :460-471
[4]  
Erlanson M, 1998, BLOOD, V92, P770
[5]   Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases [J].
Haverkos, Bradley M. ;
Pan, Zenggang ;
Gru, Alejandro A. ;
Freud, Aharon G. ;
Rabinovitch, Rachel ;
Xu-Welliver, Meng ;
Otto, Brad ;
Barrionuevo, Carlos ;
Baiocchi, Robert A. ;
Rochford, Rosemary ;
Porcu, Pierluigi .
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2016, 11 (06) :514-527
[6]   High-dose chemotherapy and hematopoietic SCT in the management of natural killer-cell malignancies [J].
Kwong, Y. -L .
BONE MARROW TRANSPLANTATION, 2009, 44 (11) :709-714
[7]   SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group [J].
Kwong, Yok-Lam ;
Kim, Won Seog ;
Lim, Soon Thye ;
Kim, Seok Jin ;
Tang, Tiffany ;
Tse, Eric ;
Leung, Anskar Y. H. ;
Chim, Chor-Sang .
BLOOD, 2012, 120 (15) :2973-2980
[8]   Penile Metastasis Secondary to Nasal NK/T-Cell Lymphoma [J].
Lan, Shih-Kai ;
Lin, Chih-Wen ;
Ho, Hsu-Chueh ;
Lee, Moon-Sing ;
Tzeng, Jeh-En ;
Su, Yu-Chieh .
UROLOGY, 2008, 72 (05) :1014-1015
[9]   Penile metastasis secondary to nasal-type extranodal natural killer/T-cell lymphoma: A case report and review of the literature [J].
Li, Yanan ;
Fu, Xiaorui ;
Wu, Jingjing ;
Yu, Chang ;
Li, Zhaoming ;
Sun, Zhenchang ;
Yan, Jiaqin ;
Nan, Feifei ;
Zhang, Xundong ;
Li, Ling ;
Li, Xin ;
Zhang, Lei ;
Li, Wencai ;
Wang, Guannan ;
Zhang, Mingzhi .
ONCOLOGY LETTERS, 2018, 15 (05) :8034-8038
[10]   Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma [J].
Shi, Y. ;
Dong, M. ;
Hong, X. ;
Zhang, W. ;
Feng, J. ;
Zhu, J. ;
Yu, L. ;
Ke, X. ;
Huang, H. ;
Shen, Z. ;
Fan, Y. ;
Li, W. ;
Zhao, X. ;
Qi, J. ;
Huang, H. ;
Zhou, D. ;
Ning, Z. ;
Lu, X. .
ANNALS OF ONCOLOGY, 2015, 26 (08) :1766-1771